Please enable JavaScript to continue using this application.

Compare $LXEO vs $UPB | Chartloom

Compare

$LXEO vs $UPB

Lexeo Therapeutics Inc · Upstream Bio Inc

LXEO

Lexeo Therapeutics Inc

UPB

Upstream Bio Inc

Compare $LXEO vs $UPB

Comparing Lexeo Therapeutics Inc and Upstream Bio Inc

LXEOLexeo Therapeutics Inc

UPBUpstream Bio Inc

LXEOLexeo Therapeutics Inc

Market cap

$254M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.4%

52W performance

-59.8%

FCF yield

-35.0%

UPBUpstream Bio Inc

Market cap

$256M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

168.72x

Rev growth (TTM)

16.0%

YTD performance

-82.6%

52W performance

-75.2%

FCF yield

-53.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LXEO

UPB

Detailed metrics comparison

LXEO

Lexeo Therapeutics Inc

UPB

Upstream Bio Inc

Market Cap

LXEO$254M

UPB$256M

Enterprise Value

LXEO$161M

UPB$176M

Price

LXEO$3.23

UPB$4.70

P/E Ratio

LXEON/A

UPBN/A

P/S Ratio

LXEO535.16x

UPB80.99x

EV/Sales

LXEO0.00x

UPB55.85x

EV/EBITDA

LXEO0.00x

UPB0.00x

P/B Ratio

LXEO1.23x

UPB1.02x

P/FCF Ratio

LXEON/A

UPBN/A

EV/FCF

LXEO-1.82x

UPB-1.29x

PEG Ratio

LXEON/A

UPBN/A

Forward P/E (NTM)

LXEON/A

UPBN/A

Forward P/S (NTM)

LXEON/A

UPB168.72x

Revenue (TTM)

LXEO$0

UPB$3M

Revenue Growth (YoY)

LXEON/A

UPB16.0%

Forward Rev Growth

LXEO466.0%

UPB-48.7%

Gross Margin (TTM)

LXEO0.0%

UPB0.0%

Operating Margin (TTM)

LXEO0.0%

UPB0.0%

EBITDA Margin (TTM)

LXEO0.0%

UPB-5376.3%

Net Margin (TTM)

LXEO0.0%

UPB-4955.7%

FCF Margin (TTM)

LXEON/A

UPB-4321.2%

Net Income (TTM)

LXEO$-87M

UPB$-157M

FCF (TTM)

LXEO$-89M

UPB$-136M

EPS (TTM)

LXEO-$1.02

UPB-$2.87

ROE (TTM)

LXEO-4185.0%

UPB-4840.0%

ROA (TTM)

LXEO-3803.0%

UPB-4657.0%

ROIC (TTM)

LXEO-4169.0%

UPB-4840.0%

Cash

LXEO$93M

UPB$79M

Debt

LXEO$584K

UPB$0

Net Cash/Debt

LXEO$92M

UPB$79M

Current Ratio (TTM)

LXEO13.89x

UPB27.99x

Quick Ratio (TTM)

LXEO13.49x

UPB27.84x

Debt/Equity (TTM)

LXEO0.00x

UPB0.00x

Debt/Assets (TTM)

LXEO0.0%

UPB0.0%

Interest Coverage (TTM)

LXEON/A

UPBN/A

Net Debt/EBITDA (TTM)

LXEO0.00x

UPB0.00x

Beta

LXEO1.62

UPB2.30

52W Performance

LXEO-59.8%

UPB-75.2%

YTD Performance

LXEO-66.4%

UPB-82.6%

% from 52W High

LXEO-70.6%

UPB-86.0%

% from 52W Low

LXEO8.4%

UPB7.7%

Asset Turnover (TTM)

LXEO0.00x

UPB0.01x

FCF Yield (TTM)

LXEO-35.0%

UPB-53.4%

Earnings Yield (TTM)

LXEO-34.4%

UPB-61.2%

Dividend Yield (TTM)

LXEON/A

UPBN/A

Rule of 40

LXEO0.0

UPB-4,305.2

EV/GP/RG

LXEON/A

UPBN/A

Ticker research

View LXEO research View UPB research

Metric	LXEO Lexeo Therapeutics Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$254M	$256M
Enterprise Value	$161M	$176M
Price	$3.23	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	535.16x	80.99x
EV/Sales	0.00x	55.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.23x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.82x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	168.72x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	466.0%	-48.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5376.3%
Net Margin (TTM)	0.0%	-4955.7%
FCF Margin (TTM)	N/A	-4321.2%
Net Income (TTM)	$-87M	$-157M
FCF (TTM)	$-89M	$-136M
EPS (TTM)	-$1.02	-$2.87
ROE (TTM)	-4185.0%	-4840.0%
ROA (TTM)	-3803.0%	-4657.0%
ROIC (TTM)	-4169.0%	-4840.0%
Financial Health
Cash	$93M	$79M
Debt	$584K	$0
Net Cash/Debt	$92M	$79M
Current Ratio (TTM)	13.89x	27.99x
Quick Ratio (TTM)	13.49x	27.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.62	2.30
52W Performance	-59.8%	-75.2%
YTD Performance	-66.4%	-82.6%
% from 52W High	-70.6%	-86.0%
% from 52W Low	8.4%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-35.0%	-53.4%
Earnings Yield (TTM)	-34.4%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,305.2
EV/GP/RG	N/A	N/A
Ticker research	View LXEO research	View UPB research

Valuation

P/S Ratio

UPB

80.99x

LXEO

535.16x

EV/FCF

LXEO

-1.82x

UPB

-1.29x

Growth & revenue

Revenue Growth TTM

UPB

16.0%

Forward Revenue Growth

LXEO

466.0%

UPB

-48.7%

Profitability & performance

Gross Margin

LXEO

0.0%

UPB

0.0%

ROE

LXEO

-4185.0%

UPB

-4840.0%

FCF Yield %

LXEO

-35.0%

UPB

-53.4%

52-Week Performance

LXEO

-59.8%

UPB

-75.2%

Detailed metrics comparison

LXEO

Lexeo Therapeutics Inc

UPB

Upstream Bio Inc

Market Cap

LXEO$254M

UPB$256M

Enterprise Value

LXEO$161M

UPB$176M

Price

LXEO$3.23

UPB$4.70

P/E Ratio

LXEON/A

UPBN/A

P/S Ratio

LXEO535.16x

UPB80.99x

EV/Sales

LXEO0.00x

UPB55.85x

EV/EBITDA

LXEO0.00x

UPB0.00x

P/B Ratio

LXEO1.23x

UPB1.02x

P/FCF Ratio

LXEON/A

UPBN/A

EV/FCF

LXEO-1.82x

UPB-1.29x

PEG Ratio

LXEON/A

UPBN/A

Forward P/E (NTM)

LXEON/A

UPBN/A

Forward P/S (NTM)

LXEON/A

UPB168.72x

Revenue (TTM)

LXEO$0

UPB$3M

Revenue Growth (YoY)

LXEON/A

UPB16.0%

Forward Rev Growth

LXEO466.0%

UPB-48.7%

Gross Margin (TTM)

LXEO0.0%

UPB0.0%

Operating Margin (TTM)

LXEO0.0%

UPB0.0%

EBITDA Margin (TTM)

LXEO0.0%

UPB-5376.3%

Net Margin (TTM)

LXEO0.0%

UPB-4955.7%

FCF Margin (TTM)

LXEON/A

UPB-4321.2%

Net Income (TTM)

LXEO$-87M

UPB$-157M

FCF (TTM)

LXEO$-89M

UPB$-136M

EPS (TTM)

LXEO-$1.02

UPB-$2.87

ROE (TTM)

LXEO-4185.0%

UPB-4840.0%

ROA (TTM)

LXEO-3803.0%

UPB-4657.0%

ROIC (TTM)

LXEO-4169.0%

UPB-4840.0%

Cash

LXEO$93M

UPB$79M

Debt

LXEO$584K

UPB$0

Net Cash/Debt

LXEO$92M

UPB$79M

Current Ratio (TTM)

LXEO13.89x

UPB27.99x

Quick Ratio (TTM)

LXEO13.49x

UPB27.84x

Debt/Equity (TTM)

LXEO0.00x

UPB0.00x

Debt/Assets (TTM)

LXEO0.0%

UPB0.0%

Interest Coverage (TTM)

LXEON/A

UPBN/A

Net Debt/EBITDA (TTM)

LXEO0.00x

UPB0.00x

Beta

LXEO1.62

UPB2.30

52W Performance

LXEO-59.8%

UPB-75.2%

YTD Performance

LXEO-66.4%

UPB-82.6%

% from 52W High

LXEO-70.6%

UPB-86.0%

% from 52W Low

LXEO8.4%

UPB7.7%

Asset Turnover (TTM)

LXEO0.00x

UPB0.01x

FCF Yield (TTM)

LXEO-35.0%

UPB-53.4%

Earnings Yield (TTM)

LXEO-34.4%

UPB-61.2%

Dividend Yield (TTM)

LXEON/A

UPBN/A

Rule of 40

LXEO0.0

UPB-4,305.2

EV/GP/RG

LXEON/A

UPBN/A

Ticker research

View LXEO research View UPB research

Metric	LXEO Lexeo Therapeutics Inc	UPB Upstream Bio Inc
Market & Valuation
Market Cap	$254M	$256M
Enterprise Value	$161M	$176M
Price	$3.23	$4.70
P/E Ratio	N/A	N/A
P/S Ratio	535.16x	80.99x
EV/Sales	0.00x	55.85x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.23x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.82x	-1.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	168.72x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	16.0%
Forward Rev Growth	466.0%	-48.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5376.3%
Net Margin (TTM)	0.0%	-4955.7%
FCF Margin (TTM)	N/A	-4321.2%
Net Income (TTM)	$-87M	$-157M
FCF (TTM)	$-89M	$-136M
EPS (TTM)	-$1.02	-$2.87
ROE (TTM)	-4185.0%	-4840.0%
ROA (TTM)	-3803.0%	-4657.0%
ROIC (TTM)	-4169.0%	-4840.0%
Financial Health
Cash	$93M	$79M
Debt	$584K	$0
Net Cash/Debt	$92M	$79M
Current Ratio (TTM)	13.89x	27.99x
Quick Ratio (TTM)	13.49x	27.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.62	2.30
52W Performance	-59.8%	-75.2%
YTD Performance	-66.4%	-82.6%
% from 52W High	-70.6%	-86.0%
% from 52W Low	8.4%	7.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-35.0%	-53.4%
Earnings Yield (TTM)	-34.4%	-61.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,305.2
EV/GP/RG	N/A	N/A
Ticker research	View LXEO research	View UPB research